Braxia Scientific Corp
Braxia Scientific Corp. operates as a medical research company with clinics that provide ketamine treatments for persons with depression and related disorders. The company also owns and operates multidisciplinary clinics that offers treatment of mental health disorders. In addition, it is involved in the research activities related to discovering and commercializing novel drugs and delivery metho… Read more
Market Cap & Net Worth: Braxia Scientific Corp (BRAXF)
Braxia Scientific Corp (PINK:BRAXF) has a market capitalization of $283.28K ($283.28K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #43179 globally and #13850 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Braxia Scientific Corp's stock price $0.00 by its total outstanding shares 283280350 (283.28 Million).
Braxia Scientific Corp Market Cap History: 2020 to 2025
Braxia Scientific Corp's market capitalization history from 2020 to 2025. Data shows change from $174.78 Million to $283.28K (-66.29% CAGR).
Braxia Scientific Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Braxia Scientific Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.60x
Braxia Scientific Corp's market cap is 0.60 times its annual revenue
1728.56x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $174.78 Million | $212.00 | -$172.72K | 824452.72x | N/A |
| 2021 | $17.28 Million | $1.01 Million | -$88.83 Million | 17.14x | N/A |
| 2022 | $5.38 Million | $1.49 Million | -$12.13 Million | 3.62x | N/A |
| 2023 | $1.13 Million | $1.88 Million | -$13.14 Million | 0.60x | N/A |
Competitor Companies of BRAXF by Market Capitalization
Companies near Braxia Scientific Corp in the global market cap rankings as of March 19, 2026.
Key companies related to Braxia Scientific Corp by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #162 globally with a market cap of $117.09 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #281 globally with a market cap of $74.80 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #344 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #500 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #162 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $117.09 Billion | $462.49 |
| #281 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $74.80 Billion | $759.05 |
| #344 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #500 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Braxia Scientific Corp Historical Marketcap From 2020 to 2025
Between 2020 and today, Braxia Scientific Corp's market cap moved from $174.78 Million to $ 283.28K, with a yearly change of -66.29%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $283.28K | -75.00% |
| 2024 | $1.13 Million | 0.00% |
| 2023 | $1.13 Million | -78.95% |
| 2022 | $5.38 Million | -68.85% |
| 2021 | $17.28 Million | -90.11% |
| 2020 | $174.78 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Braxia Scientific Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $283.28K USD |
| MoneyControl | $283.28K USD |
| MarketWatch | $283.28K USD |
| marketcap.company | $283.28K USD |
| Reuters | $283.28K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.